Zobrazeno 1 - 10
of 10
pro vyhledávání: '"B Bonaga Serrano"'
Publikováno v:
Farmacia Hospitalaria, Vol 38, Iss 3, Pp 100-104 (2014)
Objective: Web 2.0 tools are transforming the pathways health professionals use to communicate among themselves and with their patients so this situation forces a change of mind to implement them. The aim of our study is to assess the state of knowle
Externí odkaz:
https://doaj.org/article/c3e923c68baf48cf8cc630652ad0229c
Publikováno v:
Journal of Healthcare Quality Research. 33:213-218
Resumen Introduccion La administracion de antimicrobianos contribuye a la aparicion de resistencias microbianas y al incremento de infecciones por germenes multirresistentes. La patologia infecciosa, primaria o como complicacion, es una de las mas co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74b58c54e9cd4693c718526afae8a27a
https://doi.org/10.1016/j.jhqr.2018.04.003
https://doi.org/10.1016/j.jhqr.2018.04.003
Autor:
Mdp Pardo Jario, A Frutos Perez-Surio, S Gamarra Calvo, FJ Campos Montellano, T Salvador Gómez, B Bonaga Serrano, M Gimeno Gracia, MA Alcacera, JM Vinuesa Hernando
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background HIV patients live longer, and as a result are more exposed to comorbidities and even earlier onset. This leads to a polypharmacy situation, with the consequent risk of adverse effects, interactions and lack of adherence. Purpose To describ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99891f57470506074a188f47d31cf1a6
https://doi.org/10.1136/ejhpharm-2019-eahpconf.476
https://doi.org/10.1136/ejhpharm-2019-eahpconf.476
Autor:
B Bonaga Serrano, N. Berenguer Torrijo, T Salvador Gómez, M. Arenere Mendoza, P Luque Gómez, L. Sáez-Benito Suescun, I Puértolas Tena
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Linezolid is an antibiotic with a broad spectrum of activity against all clinically important Gram +bacteria, including methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci. Standard dosing is prescribed for cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0d08482fb781e52cc1054aafe4e8d7
https://europepmc.org/articles/PMC7535392/
https://europepmc.org/articles/PMC7535392/
Publikováno v:
Journal of healthcare quality research. 33(4)
The misuse and overuse of antimicrobials can contribute to an increase in antimicrobial resistance, increasing the risk of infections caused by drug-resistant bacteria. Most common surgical pathologies are infectious (either primary or as a complicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb85f013946d9b94724af28b3f9dc830
https://pubmed.ncbi.nlm.nih.gov/31610977
https://pubmed.ncbi.nlm.nih.gov/31610977
Autor:
MA Alcácera López, MJ Cumbraos Sánchez, A Frutos Perez-Surio, B Bonaga Serrano, I Puértolas Tena, E Fernández Alonso, V Compaired Turlán, MA Sagredo Samanes
Publikováno v:
Clinical pharmacy.
Background Trastuzumab containing regimens are the standard of care for HER2+ breast cancer. While intravenous trastuzumab (Tiv) is administered as a weight based dose using an initial 90 min infusion followed by a subsequent 30 min infusion, subcuta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9237559cd24cdfc5d2c6efb65ce6b1cf
https://doi.org/10.1136/ejhpharm-2017-000640.126
https://doi.org/10.1136/ejhpharm-2017-000640.126
Autor:
B Bonaga Serrano, MA Alcácera López, B Abad Bañuelos, I Puértolas Tena, B Amores Arriaga, M Merchante Andreu, T Salvador Gómez, E Guarc Prades, M Gimeno Gracia
Publikováno v:
European Journal of Hospital Pharmacy. 23:A241.2-A242
Background The emergency departments have operating characteristics that make them especially prone to the occurrence of medication errors (ME). These units represent one of the departments with the highest incidence of errors with serious outcomes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56135e0cd5675f87d54b031beef4bc0a
https://doi.org/10.1136/ejhpharm-2016-000875.548
https://doi.org/10.1136/ejhpharm-2016-000875.548
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.